HLA-C and cancer: To generate a homogeneous pMHC–TCR Signal 1, we expressed specific pp65 NLV or control gp100 pMHCs on B7-H3+ A431 cancer cells that lack endogenous surface MHC expression because of CRISPR-mediated deletion of the β2M gene.